COMMUNIQUÉS West-GlobeNewswire

Carlsmed® Reports First Quarter 2026 Financial Results
05/05/2026
First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc [...]
Dentsply Sirona Reports First Quarter 2026 Results
05/05/2026
News Summary Reported net sales of $880 million Delivered GAAP gross margin of 48.5% , GAAP net loss per share of ($0.05) Achieved adjusted gross margin of 50.7% , adjusted EBITDA margin of 14.7% , adjusted EPS of $0.27 [...]
Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
05/05/2026
DALLAS, May 05, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it intends to [...]
Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
05/05/2026
MIAMI, May 05, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
05/05/2026
Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) -- Gpr124 represents a promising novel target for improving the integrity and function of the blood-retina barrier (BRB) with the goal of slowing, halting, preventing or [...]
The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail
05/05/2026
TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- A momentous abortion issue is suddenly before the U.S. Supreme Court. Two makers of mifepristone, the drug that induces a chemical abortion, immediately petitioned the U.S [...]
SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040
05/05/2026
RANCHO CORDOVA, Californie, 05 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour la validation officielle de ses objectifs de réduction des émissions de gaz à effet de serre (GAS) par la Science Based Targets [...]
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
05/05/2026
LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately [...]
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026
05/05/2026
Lyon (France), le 5 mai 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers du premier semestre le mercredi 13 mai [...]
NTG Nordic Transport Group A/S invites to Capital Markets Day on November 18, 2026
05/05/2026
NTG Nordic Transport Group – Capital Markets Day 2026 We would like to invite institutional investors and analysts to attend our Capital Markets Day on 18 November 2026. A detailed programme will follow, but please mark [...]
IBA – ACQUISITION OF OWN SHARES
05/05/2026
Louvain-la-Neuve, Belgium, May 5 th , 2026 – 6:30 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA SA – NOTIFICATION TRANSPARENCE
05/05/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 5 mai 2026 – 18h Résumé de la notification IBA (Ion Beam Applications SA), le [...]
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026
05/05/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026 [...]
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
05/05/2026
Lyon (France), May 05, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first quarter 2026 financial results on Wednesday, May 13, 2026. The [...]
VALNEVA: Declaration of shares and voting rights - Status as of April 30, 2026 taking into account interim information as at May 5, 2026
05/05/2026
VALNEVA Declaration of shares and voting rights Status as of April 30, 2026 taking into account interim information as at May 5, 2026 [...]
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
05/05/2026
PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non- [...]
IBA – ACQUISITION D’ACTIONS PROPRES
05/05/2026
Louvain-la-Neuve, Belgique, 5 mai 2026 – 18h30 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™
05/05/2026
HACKETTSTOWN, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CORRECTION NOTICE: The press release issued by GenEmbryomics Limited on 30 April 2026, titled “GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ - Embryo Genome [...]
IBA – TRANSPARENCY NOTIFICATION
05/05/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, May 5th, 2026 – 6 p.m. Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]

Pages